Skip to content

Study on the clinical application of intelligent optimal management based on geriatric comprehensive assessment technique in elderly patients with atrial fibrillation complicated with weakness

Study on the clinical application of intelligent optimal management based on geriatric comprehensive assessment technique in elderly patients with atrial fibrillation complicated with weakness

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081670
Enrollment
Unknown
Registered
2024-03-07
Start date
2024-03-12
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrail fibrilation

Interventions

intervention group:On the basis of routine treatment,use mobile phone intelligent management program to carry out comprehensive management through remote education, key tips.

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: The patients age = 65 years old with atrial fibrillation complicated with weakness, and voluntary participation in this study and signing informed consent form.Fried weakness form which is relatively widely used in clinic, is used in the assessment of weakness.

Exclusion criteria

Exclusion criteria: ?acute cardio-cerebrovascular events, acute respiratory failure, poorly controlled infection, advanced malignant tumor?The patients with severe mental or cognitive impairment and is unable to communicate normally, ?The patients refuse to conduct a comprehensive assessment of the elderly.?Patients or family members do not use smartphones.

Design outcomes

Primary

MeasureTime frame
mininutritional assessment short form,MNA-SF;Short Physical Performance Battery, SPPB;Self-rated Fall Risk Questionnaire,FRQ;mini-mental state examination,MMSE;Self-Rating Depression Scale,SDS;Self-Rating Anxiety Scale,SAS;body mass index,BMI;CHA2 DS2-VASc ; HAS-BLED;

Secondary

MeasureTime frame
LAD;LVEF;E/e’;albumin;pre-albumin;Hemoglobin;B-type natriuretic peptide(BNP);estimated glomerular filtration rate (eGFR);

Countries

China

Contacts

Public ContactQiao Wei

China-Japan Friendship Hospital

viviqiao601@sina.com+86 10 8420 6722

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026